Harvard Catalyst Profiles

Yale University, New Haven, CT	BS	05/2007	Biology
Tufts University School of Medicine, Boston, MA	MD	05/2011
Tufts Medical Center, Boston, MA		06/2014	Internal Medicine Residency
Beth Israel Deaconess Medical Center, Boston, MA		06/2017	Hematology/Oncology Fellowship

I am an academic medical oncologist specializing in genitourinary (GU) cancers. I care for patients with prostate, bladder, kidney, and testicular cancer. My clinical activities include providing direct patient care and consultation during three-to-four half-day clinics a week and four weeks a year on the inpatient oncology ward and hematology/oncology consult services, during which time I also teach and supervise residents and fellows. In addition, I spend approximately half of my time on genitourinary oncology research, particularly focusing on immunotherapy and targeted approaches in prostate, bladder, and kidney cancers, with support from the Prostate Cancer Foundation, DoD, BIDMC, and industry partners. I am interested in clinical trial development, serving as overall Principal Investigator (PI) and site PI of several Dana-Farber/Harvard Cancer Center (DF/HCC) clinical trials that investigate immune-based and targeted therapies for GU cancers. In addition, I am the Director of GU Oncology Clinical Research for the Beth Israel-Lahey Health network. I conduct translational research as PI of the DF/HCC GU Rapid Autopsy program, a component of the Pathology core of the DF/HCC Prostate SPORE proposal. I am first author of the American Society of Clinical Oncology Self-Evaluation Program GU chapter 7th edition and ongoing reviewer. Finally, I have developed tools to improve quality of life, physician communication, and end-of-life decision-making, especially as it relates to patients with GU cancers.